Metformin as a new anti-cancer drug in adrenocortical carcinoma

Adrenocortical carcinoma (ACC) is a rare heterogeneous malignancy with poor prognosis. Since radical surgery is the only available treatment, more specific and effective drugs are urgently required. The anti-diabetic drug metformin has been associated with a decreased cancer prevalence and mortality...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Poli, Giada, Cantini, Giulia, Armignacco, Roberta, Fucci, Rossella, Santi, Raffaella, Canu, Letizia, Nesi, Gabriella, Mannelli, Massimo, Luconi, Michaela
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226535/
https://ncbi.nlm.nih.gov/pubmed/27391065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10421
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares